HomeCompareALBBY vs O

ALBBY vs O: Dividend Comparison 2026

ALBBY yields 19.90% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ALBBY wins by $38.4K in total portfolio value
10 years
ALBBY
ALBBY
● Live price
19.90%
Share price
$10.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$72.6K
Annual income
$6,667.68
Full ALBBY calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.18
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,098.20
Full O calculator →

Portfolio growth — ALBBY vs O

📍 ALBBY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodALBBYO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ALBBY + O cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ALBBY pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ALBBY
Annual income on $10K today (after 15% tax)
$1,691.54/yr
After 10yr DRIP, annual income (after tax)
$5,667.53/yr
O
Annual income on $10K today (after 15% tax)
$448.90/yr
After 10yr DRIP, annual income (after tax)
$4,333.47/yr
At 15% tax rate, ALBBY beats the other by $1,334.06/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ALBBY + O for your $10,000?

ALBBY: 50%O: 50%
100% O50/50100% ALBBY
Portfolio after 10yr
$53.4K
Annual income
$5,882.94/yr
Blended yield
11.02%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

ALBBY
No analyst data
Altman Z
7.1
Piotroski
5/9
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.6% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ALBBY buys
0
O buys
0
No recent congressional trades found for ALBBY or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricALBBYO
Forward yield19.90%5.28%
Annual dividend / share$2.00$3.23
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.1%
Portfolio after 10y$72.6K$34.2K
Annual income after 10y$6,667.68$5,098.20
Total dividends collected$41.2K$20.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: ALBBY vs O ($10,000, DRIP)

YearALBBY PortfolioALBBY Income/yrO PortfolioO Income/yrGap
1← crossover$12,690$1,990.05$10,818$607.86+$1.9KALBBY
2$15,939$2,360.17$11,786$741.30+$4.2KALBBY
3$19,825$2,770.41$12,944$910.50+$6.9KALBBY
4$24,433$3,220.46$14,343$1,127.28+$10.1KALBBY
5$29,853$3,709.39$16,053$1,408.17+$13.8KALBBY
6$36,178$4,235.71$18,167$1,776.65+$18.0KALBBY
7$43,508$4,797.38$20,815$2,266.60+$22.7KALBBY
8$51,945$5,391.92$24,179$2,927.66+$27.8KALBBY
9$61,598$6,016.43$28,521$3,833.95+$33.1KALBBY
10$72,577$6,667.68$34,218$5,098.20+$38.4KALBBY

ALBBY vs O: Complete Analysis 2026

ALBBYStock

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. It offers range of prescription drugs, over-the-counter drugs, nutritional supplements, medical devices, contact lenses, and various other health-related products through its online stores on Tmall.com and offline pharmacy outlets to business-to-customer and business-to-business customers; and pharmaceutical products, medical devices and healthcare products, health food, sexual health and family planning products, contact lenses, and medical and healthcare services through its e-commerce platform. The company also provides medical and healthcare services, including medical checkups, nucleic acid testing, medical consultation, registration, vaccination, and TCM through various channels, such as Taobao, Tmall, Alipay, Dr. Deer APP, Gaode, DingTalk, and Quark. In addition, it engages in the tracking business; provision of network hospital, healthcare related internet information, internet information, and healthcare related technical services; operation of internet hospitals; and asset management services. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited is based in Causeway Bay, Hong Kong.

Full ALBBY Calculator →

OREIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this ALBBY vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ALBBY vs SCHDALBBY vs JEPIALBBY vs KOALBBY vs MAINALBBY vs STAGALBBY vs ADCALBBY vs NNNALBBY vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.